COVID-19 Outbreak-Global Antidepressant Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The Antidepressant market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Antidepressant industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Antidepressant market can be split based on product types, major applications, and important countries as follows:
Key players in the global Antidepressant market covered in Chapter 12:
AstraZeneca
H. Lundbeck AS
Allergan PLC
Pfizer Inc.
Johnson & Johnson
Sun Pharmaceuticals Pvt Ltd
GlaxoSmithKline PLC
Sanofi
Merck & Co. Inc.
Eli Lilly and Company
In Chapter 4 and 14.1, on the basis of types, the Antidepressant market from 2015 to 2025 is primarily split into:
Selective Serotonin Reuptake Inhibitor (SSRI)
Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
Tricyclic Antidepressant (TCA)
Monoamine Oxidase Inhibitor (MAOI)
Other Products
In Chapter 5 and 14.2, on the basis of applications, the Antidepressant market from 2015 to 2025 covers:
Major Depressive Disorder
Obsessive-compulsive Disorder (OCD)
Generalized Anxiety Disorder (GAD)
Panic Disorder (PD)
Other Depressive Disorders
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Antidepressant Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Antidepressant
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Antidepressant industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Antidepressant Market Size, 2015 – 2020
2.1.2 Global Antidepressant Market Size by Type, 2015 – 2020
2.1.3 Global Antidepressant Market Size by Application, 2015 – 2020
2.1.4 Global Antidepressant Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Antidepressant Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Antidepressant Analysis
3.2 Major Players of Antidepressant
3.3 Antidepressant Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Antidepressant
3.3.3 Labor Cost of Antidepressant
3.4 Market Distributors of Antidepressant
3.5 Major Downstream Buyers of Antidepressant Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Antidepressant Market, by Type
4.1 Global Antidepressant Value and Market Share by Type (2015-2020)
4.2 Global Antidepressant Production and Market Share by Type (2015-2020)
4.3 Global Antidepressant Value and Growth Rate by Type (2015-2020)
4.3.1 Global Antidepressant Value and Growth Rate of Selective Serotonin Reuptake Inhibitor (SSRI)
4.3.2 Global Antidepressant Value and Growth Rate of Serotonin-norepinephrine Reuptake Inhibitor (SNRI)
4.3.3 Global Antidepressant Value and Growth Rate of Tricyclic Antidepressant (TCA)
4.3.4 Global Antidepressant Value and Growth Rate of Monoamine Oxidase Inhibitor (MAOI)
4.3.5 Global Antidepressant Value and Growth Rate of Other Products
4.4 Global Antidepressant Price Analysis by Type (2015-2020)
5 Antidepressant Market, by Application
5.1 Downstream Market Overview
5.2 Global Antidepressant Consumption and Market Share by Application (2015-2020)
5.3 Global Antidepressant Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Antidepressant Consumption and Growth Rate of Major Depressive Disorder (2015-2020)
5.3.2 Global Antidepressant Consumption and Growth Rate of Obsessive-compulsive Disorder (OCD) (2015-2020)
5.3.3 Global Antidepressant Consumption and Growth Rate of Generalized Anxiety Disorder (GAD) (2015-2020)
5.3.4 Global Antidepressant Consumption and Growth Rate of Panic Disorder (PD) (2015-2020)
5.3.5 Global Antidepressant Consumption and Growth Rate of Other Depressive Disorders (2015-2020)
6 Global Antidepressant Market Analysis by Regions
6.1 Global Antidepressant Sales, Revenue and Market Share by Regions
6.1.1 Global Antidepressant Sales by Regions (2015-2020)
6.1.2 Global Antidepressant Revenue by Regions (2015-2020)
6.2 North America Antidepressant Sales and Growth Rate (2015-2020)
6.3 Europe Antidepressant Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Antidepressant Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Antidepressant Sales and Growth Rate (2015-2020)
6.6 South America Antidepressant Sales and Growth Rate (2015-2020)
7 North America Antidepressant Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Antidepressant Sales, Revenue and Market Share by Countries
7.2.1 North America Antidepressant Sales by Countries (2015-2020)
7.2.2 North America Antidepressant Revenue by Countries (2015-2020)
7.3 United States Antidepressant Sales and Growth Rate (2015-2020)
7.4 Canada Antidepressant Sales and Growth Rate (2015-2020)
7.5 Mexico Antidepressant Sales and Growth Rate (2015-2020)
8 Europe Antidepressant Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Antidepressant Sales, Revenue and Market Share by Countries
8.2.1 Europe Antidepressant Sales by Countries (2015-2020)
8.2.2 Europe Antidepressant Revenue by Countries (2015-2020)
8.3 Germany Antidepressant Sales and Growth Rate (2015-2020)
8.4 UK Antidepressant Sales and Growth Rate (2015-2020)
8.5 France Antidepressant Sales and Growth Rate (2015-2020)
8.6 Italy Antidepressant Sales and Growth Rate (2015-2020)
8.7 Spain Antidepressant Sales and Growth Rate (2015-2020)
8.8 Russia Antidepressant Sales and Growth Rate (2015-2020)
9 Asia Pacific Antidepressant Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Antidepressant Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Antidepressant Sales by Countries (2015-2020)
9.2.2 Asia Pacific Antidepressant Revenue by Countries (2015-2020)
9.3 China Antidepressant Sales and Growth Rate (2015-2020)
9.4 Japan Antidepressant Sales and Growth Rate (2015-2020)
9.5 South Korea Antidepressant Sales and Growth Rate (2015-2020)
9.6 India Antidepressant Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Antidepressant Sales and Growth Rate (2015-2020)
9.8 Australia Antidepressant Sales and Growth Rate (2015-2020)
10 Middle East and Africa Antidepressant Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Antidepressant Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Antidepressant Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Antidepressant Revenue by Countries (2015-2020)
10.3 Saudi Arabia Antidepressant Sales and Growth Rate (2015-2020)
10.4 UAE Antidepressant Sales and Growth Rate (2015-2020)
10.5 Egypt Antidepressant Sales and Growth Rate (2015-2020)
10.6 Nigeria Antidepressant Sales and Growth Rate (2015-2020)
10.7 South Africa Antidepressant Sales and Growth Rate (2015-2020)
11 South America Antidepressant Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Antidepressant Sales, Revenue and Market Share by Countries
11.2.1 South America Antidepressant Sales by Countries (2015-2020)
11.2.2 South America Antidepressant Revenue by Countries (2015-2020)
11.3 Brazil Antidepressant Sales and Growth Rate (2015-2020)
11.4 Argentina Antidepressant Sales and Growth Rate (2015-2020)
11.5 Columbia Antidepressant Sales and Growth Rate (2015-2020)
11.6 Chile Antidepressant Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 AstraZeneca
12.1.1 AstraZeneca Basic Information
12.1.2 Antidepressant Product Introduction
12.1.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
12.2 H. Lundbeck AS
12.2.1 H. Lundbeck AS Basic Information
12.2.2 Antidepressant Product Introduction
12.2.3 H. Lundbeck AS Production, Value, Price, Gross Margin 2015-2020
12.3 Allergan PLC
12.3.1 Allergan PLC Basic Information
12.3.2 Antidepressant Product Introduction
12.3.3 Allergan PLC Production, Value, Price, Gross Margin 2015-2020
12.4 Pfizer Inc.
12.4.1 Pfizer Inc. Basic Information
12.4.2 Antidepressant Product Introduction
12.4.3 Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Basic Information
12.5.2 Antidepressant Product Introduction
12.5.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.6 Sun Pharmaceuticals Pvt Ltd
12.6.1 Sun Pharmaceuticals Pvt Ltd Basic Information
12.6.2 Antidepressant Product Introduction
12.6.3 Sun Pharmaceuticals Pvt Ltd Production, Value, Price, Gross Margin 2015-2020
12.7 GlaxoSmithKline PLC
12.7.1 GlaxoSmithKline PLC Basic Information
12.7.2 Antidepressant Product Introduction
12.7.3 GlaxoSmithKline PLC Production, Value, Price, Gross Margin 2015-2020
12.8 Sanofi
12.8.1 Sanofi Basic Information
12.8.2 Antidepressant Product Introduction
12.8.3 Sanofi Production, Value, Price, Gross Margin 2015-2020
12.9 Merck & Co. Inc.
12.9.1 Merck & Co. Inc. Basic Information
12.9.2 Antidepressant Product Introduction
12.9.3 Merck & Co. Inc. Production, Value, Price, Gross Margin 2015-2020
12.10 Eli Lilly and Company
12.10.1 Eli Lilly and Company Basic Information
12.10.2 Antidepressant Product Introduction
12.10.3 Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Antidepressant Market Forecast
14.1 Global Antidepressant Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Selective Serotonin Reuptake Inhibitor (SSRI) Market Value and Volume Forecast (2020-2025)
14.1.2 Serotonin-norepinephrine Reuptake Inhibitor (SNRI) Market Value and Volume Forecast (2020-2025)
14.1.3 Tricyclic Antidepressant (TCA) Market Value and Volume Forecast (2020-2025)
14.1.4 Monoamine Oxidase Inhibitor (MAOI) Market Value and Volume Forecast (2020-2025)
14.1.5 Other Products Market Value and Volume Forecast (2020-2025)
14.2 Global Antidepressant Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Major Depressive Disorder Market Value and Volume Forecast (2020-2025)
14.2.2 Obsessive-compulsive Disorder (OCD) Market Value and Volume Forecast (2020-2025)
14.2.3 Generalized Anxiety Disorder (GAD) Market Value and Volume Forecast (2020-2025)
14.2.4 Panic Disorder (PD) Market Value and Volume Forecast (2020-2025)
14.2.5 Other Depressive Disorders Market Value and Volume Forecast (2020-2025)
14.3 Antidepressant Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Antidepressant
Table Product Specification of Antidepressant
Table Antidepressant Key Market Segments
Table Key Players Antidepressant Covered
Figure Global Antidepressant Market Size, 2015 – 2025
Table Different Types of Antidepressant
Figure Global Antidepressant Value ($) Segment by Type from 2015-2020
Figure Global Antidepressant Market Share by Types in 2019
Table Different Applications of Antidepressant
Figure Global Antidepressant Value ($) Segment by Applications from 2015-2020
Figure Global Antidepressant Market Share by Applications in 2019
Figure Global Antidepressant Market Share by Regions in 2019
Figure North America Antidepressant Production Value ($) and Growth Rate (2015-2020)
Figure Europe Antidepressant Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Antidepressant Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Antidepressant Production Value ($) and Growth Rate (2015-2020)
Figure South America Antidepressant Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Antidepressant
Table Upstream Raw Material Suppliers of Antidepressant with Contact Information
Table Major Players Headquarters, and Service Area of Antidepressant
Figure Major Players Production Value Market Share of Antidepressant in 2019
Table Major Players Antidepressant Product Types in 2019
Figure Production Process of Antidepressant
Figure Manufacturing Cost Structure of Antidepressant
Figure Channel Status of Antidepressant
Table Major Distributors of Antidepressant with Contact Information
Table Major Downstream Buyers of Antidepressant with Contact Information
Table Global Antidepressant Value ($) by Type (2015-2020)
Table Global Antidepressant Value Share by Type (2015-2020)
Figure Global Antidepressant Value Share by Type (2015-2020)
Table Global Antidepressant Production by Type (2015-2020)
Table Global Antidepressant Production Share by Type (2015-2020)
Figure Global Antidepressant Production Share by Type (2015-2020)
Figure Global Antidepressant Value ($) and Growth Rate of Selective Serotonin Reuptake Inhibitor (SSRI) (2015-2020)
Figure Global Antidepressant Value ($) and Growth Rate of Serotonin-norepinephrine Reuptake Inhibitor (SNRI) (2015-2020)
Figure Global Antidepressant Value ($) and Growth Rate of Tricyclic Antidepressant (TCA) (2015-2020)
Figure Global Antidepressant Value ($) and Growth Rate of Monoamine Oxidase Inhibitor (MAOI) (2015-2020)
Figure Global Antidepressant Value ($) and Growth Rate of Other Products (2015-2020)
Figure Global Antidepressant Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Antidepressant Consumption by Application (2015-2020)
Table Global Antidepressant Consumption Market Share by Application (2015-2020)
Figure Global Antidepressant Consumption Market Share by Application (2015-2020)
Figure Global Antidepressant Consumption and Growth Rate of Major Depressive Disorder (2015-2020)
Figure Global Antidepressant Consumption and Growth Rate of Obsessive-compulsive Disorder (OCD) (2015-2020)
Figure Global Antidepressant Consumption and Growth Rate of Generalized Anxiety Disorder (GAD) (2015-2020)
Figure Global Antidepressant Consumption and Growth Rate of Panic Disorder (PD) (2015-2020)
Figure Global Antidepressant Consumption and Growth Rate of Other Depressive Disorders (2015-2020)
Figure Global Antidepressant Sales and Growth Rate (2015-2020)
Figure Global Antidepressant Revenue (M USD) and Growth (2015-2020)
Table Global Antidepressant Sales by Regions (2015-2020)
Table Global Antidepressant Sales Market Share by Regions (2015-2020)
Table Global Antidepressant Revenue (M USD) by Regions (2015-2020)
Table Global Antidepressant Revenue Market Share by Regions (2015-2020)
Table Global Antidepressant Revenue Market Share by Regions in 2015
Table Global Antidepressant Revenue Market Share by Regions in 2019
Figure North America Antidepressant Sales and Growth Rate (2015-2020)
Figure Europe Antidepressant Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Antidepressant Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Antidepressant Sales and Growth Rate (2015-2020)
Figure South America Antidepressant Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Antidepressant Revenue (M USD) and Growth (2015-2020)
Table North America Antidepressant Sales by Countries (2015-2020)
Table North America Antidepressant Sales Market Share by Countries (2015-2020)
Table North America Antidepressant Revenue (M USD) by Countries (2015-2020)
Table North America Antidepressant Revenue Market Share by Countries (2015-2020)
Figure United States Antidepressant Sales and Growth Rate (2015-2020)
Figure Canada Antidepressant Sales and Growth Rate (2015-2020)
Figure Mexico Antidepressant Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Antidepressant Revenue (M USD) and Growth (2015-2020)
Table Europe Antidepressant Sales by Countries (2015-2020)
Table Europe Antidepressant Sales Market Share by Countries (2015-2020)
Table Europe Antidepressant Revenue (M USD) by Countries (2015-2020)
Table Europe Antidepressant Revenue Market Share by Countries (2015-2020)
Figure Germany Antidepressant Sales and Growth Rate (2015-2020)
Figure UK Antidepressant Sales and Growth Rate (2015-2020)
Figure France Antidepressant Sales and Growth (2015-2020)
Figure Italy Antidepressant Sales and Growth (2015-2020)
Figure Spain Antidepressant Sales and Growth (2015-2020)
Figure Russia Antidepressant Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Antidepressant Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Antidepressant Sales by Countries (2015-2020)
Table Asia Pacific Antidepressant Sales Market Share by Countries (2015-2020)
Table Asia Pacific Antidepressant Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Antidepressant Revenue Market Share by Countries (2015-2020)
Figure China Antidepressant Sales and Growth Rate (2015-2020)
Figure Japan Antidepressant Sales and Growth Rate (2015-2020)
Figure South Korea Antidepressant Sales and Growth (2015-2020)
Figure India Antidepressant Sales and Growth (2015-2020)
Figure Southeast Asia Antidepressant Sales and Growth (2015-2020)
Figure Australia Antidepressant Sales and Growth (2015-2020)
Figure Middle East Antidepressant Revenue (M USD) and Growth (2015-2020)
Table Middle East Antidepressant Sales by Countries (2015-2020)
Table Middle East and Africa Antidepressant Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Antidepressant Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Antidepressant Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Antidepressant Sales and Growth Rate (2015-2020)
Figure UAE Antidepressant Sales and Growth Rate (2015-2020)
Figure Egypt Antidepressant Sales and Growth (2015-2020)
Figure Nigeria Antidepressant Sales and Growth (2015-2020)
Figure South Africa Antidepressant Sales and Growth (2015-2020)
Figure South America Antidepressant Revenue (M USD) and Growth (2015-2020)
Table South America Antidepressant Sales by Countries (2015-2020)
Table South America Antidepressant Sales Market Share by Countries (2015-2020)
Table South America Antidepressant Revenue (M USD) by Countries (2015-2020)
Table South America Antidepressant Revenue Market Share by Countries (2015-2020)
Figure Brazil Antidepressant Sales and Growth Rate (2015-2020)
Figure Argentina Antidepressant Sales and Growth Rate (2015-2020)
Figure Columbia Antidepressant Sales and Growth (2015-2020)
Figure Chile Antidepressant Sales and Growth (2015-2020)
Figure Top 3 Market Share of Antidepressant Companies in 2019
Figure Top 6 Market Share of Antidepressant Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table AstraZeneca Profile
Table AstraZeneca Product Introduction
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table H. Lundbeck AS Profile
Table H. Lundbeck AS Product Introduction
Figure H. Lundbeck AS Production and Growth Rate
Figure H. Lundbeck AS Value ($) Market Share 2015-2020
Table Allergan PLC Profile
Table Allergan PLC Product Introduction
Figure Allergan PLC Production and Growth Rate
Figure Allergan PLC Value ($) Market Share 2015-2020
Table Pfizer Inc. Profile
Table Pfizer Inc. Product Introduction
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Sun Pharmaceuticals Pvt Ltd Profile
Table Sun Pharmaceuticals Pvt Ltd Product Introduction
Figure Sun Pharmaceuticals Pvt Ltd Production and Growth Rate
Figure Sun Pharmaceuticals Pvt Ltd Value ($) Market Share 2015-2020
Table GlaxoSmithKline PLC Profile
Table GlaxoSmithKline PLC Product Introduction
Figure GlaxoSmithKline PLC Production and Growth Rate
Figure GlaxoSmithKline PLC Value ($) Market Share 2015-2020
Table Sanofi Profile
Table Sanofi Product Introduction
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Table Merck & Co. Inc. Profile
Table Merck & Co. Inc. Product Introduction
Figure Merck & Co. Inc. Production and Growth Rate
Figure Merck & Co. Inc. Value ($) Market Share 2015-2020
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Product Introduction
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2015-2020
Table Market Driving Factors of Antidepressant
Table Merger, Acquisition and New Investment
Table Global Antidepressant Market Value ($) Forecast, by Type
Table Global Antidepressant Market Volume Forecast, by Type
Figure Global Antidepressant Market Value ($) and Growth Rate Forecast of Selective Serotonin Reuptake Inhibitor (SSRI) (2020-2025)
Figure Global Antidepressant Market Volume ($) and Growth Rate Forecast of Selective Serotonin Reuptake Inhibitor (SSRI) (2020-2025)
Figure Global Antidepressant Market Value ($) and Growth Rate Forecast of Serotonin-norepinephrine Reuptake Inhibitor (SNRI) (2020-2025)
Figure Global Antidepressant Market Volume ($) and Growth Rate Forecast of Serotonin-norepinephrine Reuptake Inhibitor (SNRI) (2020-2025)
Figure Global Antidepressant Market Value ($) and Growth Rate Forecast of Tricyclic Antidepressant (TCA) (2020-2025)
Figure Global Antidepressant Market Volume ($) and Growth Rate Forecast of Tricyclic Antidepressant (TCA) (2020-2025)
Figure Global Antidepressant Market Value ($) and Growth Rate Forecast of Monoamine Oxidase Inhibitor (MAOI) (2020-2025)
Figure Global Antidepressant Market Volume ($) and Growth Rate Forecast of Monoamine Oxidase Inhibitor (MAOI) (2020-2025)
Figure Global Antidepressant Market Value ($) and Growth Rate Forecast of Other Products (2020-2025)
Figure Global Antidepressant Market Volume ($) and Growth Rate Forecast of Other Products (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Major Depressive Disorder (2020-2025)
Figure Market Volume and Growth Rate Forecast of Major Depressive Disorder (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Obsessive-compulsive Disorder (OCD) (2020-2025)
Figure Market Volume and Growth Rate Forecast of Obsessive-compulsive Disorder (OCD) (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Generalized Anxiety Disorder (GAD) (2020-2025)
Figure Market Volume and Growth Rate Forecast of Generalized Anxiety Disorder (GAD) (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Panic Disorder (PD) (2020-2025)
Figure Market Volume and Growth Rate Forecast of Panic Disorder (PD) (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Other Depressive Disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Other Depressive Disorders (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Research Methodology:
Antidepressant Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|